Try our beta test site
Trial record 1 of 2 for:    109493
Previous Study | Return to List | Next Study

GSK1572932A Antigen-Specific Cancer Immunotherapeutic as Adjuvant Therapy in Patients With Non-Small Cell Lung Cancer

This study has been terminated.
(The study was terminated following assessment of the lack of efficacy of the study product by the Independent Data monitoring Committee for the study.)
Information provided by (Responsible Party):
GlaxoSmithKline Identifier:
First received: May 29, 2007
Last updated: November 19, 2015
Last verified: November 2015